Literature DB >> 36191180

Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel.

Linghui Li1,2,3, Yan Chai1, Weiyu Peng4, Delin Li5,6, Litao Sun7, George Fu Gao1,2, Jianxun Qi1, Haixia Xiao6, William Jun Liu8, Mark von Itzstein3, Feng Gao6,9.   

Abstract

Influenza virus neuraminidase (NA) is an important target for antiviral development because it plays a crucial role in releasing newly assembled viruses. Two unique influenza-like virus genomes were recently reported in the Wuhan Asiatic toad and Wuhan spiny eel. Their NA genes appear to be highly divergent from all known influenza NAs, raising key questions as to whether the Asiatic toad influenza-like virus NA (tNA) and spiny eel NA (eNA) have canonical NA activities and structures and whether they show sensitivity to NA inhibitors (NAIs). Here, we found that both tNA and eNA have neuraminidase activities. A detailed structural analysis revealed that tNA and eNA present similar overall structures to currently known NAs, with a conserved calcium binding site. Inhibition assays indicated that tNA is resistant to NAIs, while eNA is still sensitive to NAIs. E119 is conserved in canonical NAs. The P119E substitution in tNA can restore sensitivity to NAIs, and, in contrast, the E119P substitution in eNA decreased its sensitivity to NAIs. The structures of NA-inhibitor complexes further provide a detailed insight into NA-inhibitor interactions at the atomic level. Moreover, tNA and eNA have unique N-glycosylation sites compared with canonical NAs. Collectively, the structural features, NA activities, and sensitivities to NAIs suggest that fish- and amphibian-derived influenza-like viruses may circulate in these vertebrates. More attention should be paid to these influenza-like viruses because their NA molecules may play roles in the emergence of NAI resistance.

Entities:  

Keywords:  Wuhan Asiatic toad influenza-like virus; Wuhan spiny eel influenza-like virus; crystal structures; drug resistance; neuraminidase (NA)

Mesh:

Substances:

Year:  2022        PMID: 36191180      PMCID: PMC9586306          DOI: 10.1073/pnas.2210724119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  55 in total

1.  Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.

Authors:  Chonnikan Hanpaibool; Matina Leelawiwat; Kaito Takahashi; Thanyada Rungrotmongkol
Journal:  J Comput Aided Mol Des       Date:  2019-11-26       Impact factor: 3.686

2.  Influenza A virus N5 neuraminidase has an extended 150-cavity.

Authors:  Mingyang Wang; Jianxun Qi; Yue Liu; Christopher J Vavricka; Yan Wu; Qing Li; George F Gao
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

3.  Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site.

Authors:  Xueyong Zhu; Hua Yang; Zhu Guo; Wenli Yu; Paul J Carney; Yan Li; Li-Mei Chen; James C Paulson; Ruben O Donis; Suxiang Tong; James Stevens; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

4.  Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus.

Authors:  Qing Li; Xiaoman Sun; Zhixin Li; Yue Liu; Christopher J Vavricka; Jianxun Qi; George F Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

5.  E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.

Authors:  Arnaud G L'Huillier; Yacine Abed; Tom J Petty; Samuel Cordey; Yves Thomas; Xavier Bouhy; Manuel Schibler; Audrey Simon; Yves Chalandon; Christian van Delden; Evgeny Zdobnov; Patricia Boquete-Suter; Guy Boivin; Laurent Kaiser
Journal:  J Infect Dis       Date:  2015-05-17       Impact factor: 5.226

6.  Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism.

Authors:  M N Janakiraman; C L White; W G Laver; G M Air; M Luo
Journal:  Biochemistry       Date:  1994-07-12       Impact factor: 3.162

7.  Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.

Authors:  Yan Wu; Feng Gao; Jianxun Qi; Yuhai Bi; Lifeng Fu; Sankar Mohan; Yuhang Chen; Xuebing Li; B Mario Pinto; Christopher J Vavricka; Po Tien; George F Gao
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

8.  Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding.

Authors:  C Liu; M C Eichelberger; R W Compans; G M Air
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.

Authors:  C U Kim; W Lew; M A Williams; H Liu; L Zhang; S Swaminathan; N Bischofberger; M S Chen; D B Mendel; C Y Tai; W G Laver; R C Stevens
Journal:  J Am Chem Soc       Date:  1997-01-29       Impact factor: 15.419

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.